2011Chinese Journal of Hospital PharmacyRequires access

Experimental study on the anti-platelet aggregation and anti-coagulant activity of isoliensinine

Luo Shun-de

Open publisher page 1 citations

Abstract

OBJECTIVE To investigate the inhibitory effects of isoliensinine on platelet aggregation in rabbits and coagulation function in rats.METHODS Inhibition rates of platelet aggregation for isoliensinine in vivo and vitro were determined by the model of platelet aggregation induced by adenosine diphosphate.The effects of isoliensinine were also evaluated on prothrombin time(PT),activated partial thromboplastin time(APTT) and thrombin time(TT).RESULTS Isoliensinine inhibited platelet aggregation in vitro at the concentration of 4 and 8 mg·L-1,inhibition rates were 14.4% and 27.9%.Isoliensinine inhibited platelet aggregation in vivo at the concentration of 5 and 10 mg·kg-1,inhibition rates were 20.0% and 32.6%.Isoliensinine also markedly prolonged PT,APTT and TT also.CONCLUSION Isoliensinine exerted remarkable effects against platelet aggregation and coagulation in animal study.

About this research paper

What this paper is about

OBJECTIVE To investigate the inhibitory effects of isoliensinine on platelet aggregation in rabbits and coagulation function in rats.METHODS Inhibition rates of platelet aggregation for isoliensinine in vivo and vitro were determined by the model of platelet aggregation induced by adenosine diphosphate.The effects of isoliensinine were also evaluated on prothrombin time(PT),activated partial thromboplastin time(APTT) and thrombin time(TT).RESULTS Isoliensinine inhibited platelet aggregation in vitro at the concentration of 4 and 8 mg·L-1,inhibition rates were 14.4% and 27.9%.Isoliensinine inhibited platelet aggregation in vivo at the concentration of 5 and 10 mg·kg-1,inhibition rates were 20.0% and 32.6%.Isoliensinine also markedly prolonged PT,APTT and TT also.CONCLUSION Isoliensinine exerted remarkable effects against platelet aggregation and coagulation in animal study.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE To investigate the inhibitory effects of isoliensinine on platelet aggregation in rabbits and coagulation function in rats.METHODS Inhibition rates of platelet aggregation for isoliensinine in vivo and vitro were determined by the model of platelet aggregation induced by adenosine diphosphate.The effects of isoliensinine were also evaluated on prothrombin time(PT),activated partial thromboplastin time(APTT) and thrombin time(TT).RESULTS Isoliensinine inhibited platelet aggregation in vitro at the concentration of 4 and 8 mg·L-1,inhibition rates were 14.4% and 27.9%.Isoliensinine inhibited platelet aggregation in vivo at the concentration of 5 and 10 mg·kg-1,inhibition rates were 20.0% and 32.6%.Isoliensinine also markedly prolonged PT,APTT and TT also.CONCLUSION Isoliensinine exerted remarkable effects against platelet aggregation and coagulation in animal study.

Key concepts: Partial thromboplastin time, Chemistry, Platelet, Prothrombin time, In vivo, Coagulation, Pharmacology, Platelet aggregation

Related papers

Back to paper searchBrowse research topicsOriginal source
Experimental study on the anti-platelet aggregation and anti-coagulant activity of isoliensinine — Research Paper | ScholarLens